Amer Karam, MD

Gynecologic Oncology, Gynecology, Obstetrics & Gynecology
Male
English, French, Arabic
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
A87777
(310) 794-7274 (Westwood)
(310) 829-5471 (Santa Monica)
(310) 794-9110 (Westwood)
(310) 829-6192 (Santa Monica)
akaram@mednet.ucla.edu
UCLA OBGYN Specialty Suite
200 UCLA Medical Plaza, Suite 220
Los Angeles, CA 90095
Santa Monica
Santa Monica UCLA Hematology Oncology at 2020
2020 Santa Monica Blvd, Suite 600
Santa Monica, CA 90404
Hospice and Palliative Care, American Board of Obstetrics and Gynecology, 2010
Obstetrics & Gynecology, American Board of Obstetrics and Gynecology, 2009, 2011
Breast Surgical Oncology, Memorial Sloan-Kettering Cancer Center, 2007 - 2008
Gynecologic Oncology, UCLA School of Medicine, 2004 - 2007
Obstetrics & Gynecology, Johns Hopkins Hospital, 2001 - 2004
Obstetrics & Gynecology, Johns Hopkins Hospital, 2000 - 2001
MD, American University of Beirut Medical School, 2000
| Abnormal Pap Smear, Abnormal Vaginal Bleeding, Benign Breast Disease, Benign Ovarian Cysts, Breast Cancer, Breast Masses, Cervical Cancer, Colposcopy, Condyloma, Cryotherapy, Endometriosis, Endoscopy, Fibroids, Genetics, Gynecologic Oncology, Laparoscopy, Laser, Oncology, Ovarian Cancer, Robotic Surgery, Trophoblastic Disease, Uterine Cancer, Vaginal Cancer, Vulvar Cancer, Vulvar Disease |
Physician, Obstetrics and Gynecology, Gynecologic Oncology, UCLA Santa Monica Hematology Oncology at 2020
Dr. Karam offers many treatment options for the surgical treatment of gynecologic malignancies including: radical ovarian cancer surgery and the latest advances in minimally invasive surgery and robotic surgery and their application in the treatment of complex benign gynecologic conditions such as uterine fibroids and endometriosis. He is also uniquely qualified to treat and diagnose patients with hereditary breast and/or ovarian cancer as well as patients at high risk of developing breast cancer and offers many options for the treatment of patients with breast cancer including: sentinel lymph node biopsy, breast conserving surgery as well as skin and nipple-sparing mastectomy.
![]()
- America's Most Compassionate Doctors, 2009 (Rated & awarded by patients)
- Patient's Choice Awards, 2008 - 2009 (Rated & awarded by patients)
- Breast Cancer Committee 2008-2009
The Society of Surgical Oncology - Excellence in Teaching Award 2007
Cedars-Sinai Medical Center, Department of Obstetrics and Gynecology - Outstanding Resident Award 2004
GBMC Healthcare, Department Obstetrics and Gynecology - Golden Trocar Award 2004
The Johns Hopkins Hospital, Division of Gynecologic Specialties - Excellence in Teaching Award 2004
The Johns Hopkins Hospital, Department of Gynecology and Obstetrics - Ungula Sinistra Award 2004
The Johns Hopkins Hospital, Kelly Gynecologic Oncology Service - Administrative Chief Resident 2003-2004
The Johns Hopkins Hospital, Department of Gynecology and Obstetrics - Berlex Best Resident Teaching Award 2002
The Johns Hopkins Hospital, Department of Gynecology and Obstetrics
1. Karam AK, Hsu M, Patil S, Stempel M, Traina T, Ho A, Cody HS, Morrow M, Gemignani ML. Predictors of Completion Axillary Lymph Node Dissection in Patients with Positive Sentinel Lymph Nodes. Annals of Surgical Oncology Volume 16, Number 7, Pages 1952-1958, July 2009.
2. Karam AK, Wang Chiang J, Fung E, Nossov V, Karlan BY. Extreme Drug Resistance Assay Results Do Not Influence Survival in Women with Epithelial Ovarian Cancer. Gynecologic Oncology Volume 114, Number 2, Pages 246-252, August 2009.
3. Karam AK, Stempel M, Barakat RR, Morrow M, Gemignani ML. Patients with a History of Epithelial Ovarian Cancer Presenting With a Breast and/or Axillary Mass. Gynecologic Oncology Volume 112, Number 3, Pages 490-495, March 2009.
4. Karam AK, Stempel M, Cody HS, Port ER. Reoperative Sentinel Lymph Node Biopsy after Previous Mastectomy. Journal of the American College of Surgeons Volume 207, Number 4, Pages 543-548, October 2008.
5. Karam AK, Berek JS, Stenson A, Rao JY, Dorigo O. HER-2/Neu Targeting for Recurrent Vulva Paget's Disease: A Case Report and Literature Review. Gynecologic Oncology Volume 111, Number 3, Pages 568-571, December 2008.
6. Karam AK, Santillan A, Bristow RE, Giuntoli R 2nd, Gardner GJ, Cass I, Karlan BY, Li AJ. Tertiary cytoreductive surgery in recurrent ovarian cancer: Selection criteria and survival outcome. Gynecologic Oncology Volume 104, Number 2, Pages 377-80, February 2007.
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.
Find out how to refer a patient
















